Roivant Sciences Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-397.91	-356.73	4,231	-1,115	-924.12
Depreciation & Amortization	3.35	14.07	22.04	18.86	5.93
Stock-Based Compensation	346.17	289.03	199.63	217.78	564.96
Other Adjustments	-80.16	-708.77	-5,237	29.09	-340.22
Changes in Accounts Payable	3.42	-18.17	22.68	4.36	15.4
Changes in Accrued Expenses	59.33	-10.07	62.13	57.53	50.6
Changes in Income Taxes Payable	85.05	-10.05	9.93	-	-
Changes in Other Operating Activities	-769.59	-38.76	-75.7	-55.54	-50.28
Operating Cash Flow	-750.35	-839.45	-765.27	-843.39	-677.73
Capital Expenditures	-8.21	-4.6	-1.38	-12.69	-17.44
Purchases of Investments	-4,796	-4,062	-	-	-
Proceeds from Sale of Investments	4,129	1,960	-	114.56	320.17
Proceeds from Business Divestments	-	370.97	5,281	-	-
Other Investing Activities	-6.94	-31.14	-75.89	-146.14	0.56
Investing Cash Flow	-682.33	-1,766	5,204	-44.27	303.3
Long-Term Debt Issued	-	-	-	159.9	36.4
Long-Term Debt Repaid	-	-52.75	-30.71	-30.14	-21.59
Net Long-Term Debt Issued (Repaid)	-	-52.75	-30.71	129.76	14.81
Issuance of Common Stock	269.51	50.63	255.09	315.11	313.84
Repurchase of Common Stock	-366.72	-1,330	-37.76	-10.88	-
Net Common Stock Issued (Repurchased)	-97.22	-1,280	217.34	304.23	313.84
Other Financing Activities	231.46	112.78	232.73	65.48	-21.85
Financing Cash Flow	134.24	-1,220	419.36	499.46	306.79
Effect of Exchange Rate Changes on Cash and Cash Equivalents	3.77	0.75	0.62	6.28	-
Net Cash Flow	-1,295	-3,825	4,858	-381.92	-67.64
Free Cash Flow	-758.56	-844.05	-766.65	-856.08	-695.17
FCF Margin	-9183.51%	-2905.21%	-2343.56%	-1397.00%	-1257.40%
Free Cash Flow Per Share	-1.09	-1.16	-0.92	-1.20	-1.04
Levered Free Cash Flow	-926.43	-292.31	4,358	-866.76	-826.24
Unlevered Free Cash Flow	-1,401	-1,142	4,516	-1,168	-1,348

SEC Filings: 10-K · 10-Q